Objetivo Over the last 20 years, monoclonal antibodies (mAbs) against several thousand proteins have become commercially available. When considering the number of proteins predicted in the human and other genomes, this number is still far from meeting the current demand to perform comprehensive proteome analyses of biological systems and it therefore represents a bottleneck to further development of proteome research. In view of general needs in the area of biomedical research, a high throughput development and production of mAbs is considered one of the most promising approaches to build up a research and biotechnology unit.This was a strong argument for the establishment of the Centre for Monoclonal Antibody Production at the University of Rijeka (CAPRI). Given the already made investment into infrastructure and basic equipment by the University, the proposed SSA project will be used for upgrading the capabilities of CAPRI in order to enable it to run a high-throughput production of mAbs and increasing its networking activity with potential mAbs users - research teams from universities and public research institutes, but also from the private sector. By having a large collection of specific mAbs, CAPRI can be a driving force for the development of small enterprises.The immediate goal of the project is to enable the CAPRI staff to generate mAbs against all proteins of several relevant human viruses, starting from mAbs against the entire proteome of the Variccela Zoster Virus (VZV). By making these mAbs available to research groups and companies from Croatia and from the region, the project will not only be beneficial for upgrading the scientific competence of Croatian bioscience, but it should also contribute to strengthening the scientific and technological cooperation within the region and improving its competitiveness for participating in the EU Framework Programmes (especially in the thematic priority "Life Sciences, Genomics and Biotechnology for Health"). Ámbito científico natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomicsmedical and health sciencesbasic medicineimmunologyimmunisationnatural sciencesbiological sciencesmicrobiologyvirologynatural sciencesphysical sciencesopticsmicroscopyconfocal microscopynatural sciencesbiological sciencesgeneticsgenomes Programa(s) FP6-INCO - Specific measures in support of international cooperation: Specific activities covering wider field of research under the Focusing and Integrating Community Research programme 2002-2006. Tema(s) INCO-2004-C-WBC-SSA - Reinforcement of the WBC research capacities INCO - Specific measures in support of international co-operation Convocatoria de propuestas FP6-2004-INCO-WBC/SSA-3 Consulte otros proyectos de esta convocatoria Régimen de financiación SSA - Specific Support Action Coordinador FACULTY OF MEDICINE UNIVERSITY OF RIJEKA Aportación de la UE Sin datos Dirección B. Branchetta 20 RIJEKA Croacia Ver en el mapa Enlaces Sitio web Opens in new window Coste total Sin datos Participantes (2) Ordenar alfabéticamente Ordenar por aportación de la UE Ampliar todo Contraer todo LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN Alemania Aportación de la UE Sin datos Dirección Geschwister-Scholl-Platz 1 MUENCHEN Ver en el mapa Enlaces Sitio web Opens in new window Coste total Sin datos MEDICAL FACULTY UNIVERSITY OF MOSTAR Bosnia y Herzegovina Aportación de la UE Sin datos Dirección Petra Kresimira IV bb MOSTAR Ver en el mapa Enlaces Sitio web Opens in new window Coste total Sin datos
